Resveratrol increases CD68+ Kupffer cells colocalized with adipose differentiation-related protein and ameliorates high-fat-diet-induced fatty liver in mice

Molecular Nutrition and Food Research

Volumn 59, Issue 6, 2015, Pages 1155-1170

  Nishikawa, Kahoko ^a   Iwaya, Keiichi ^b   Kinoshita, Manabu ^b   Fujiwara, Yoko ^c   Akao, Mai ^c   Sonoda, Mariko ^c   Thiruppathi, Suresh ^d   Suzuki, Takayoshi ^d   Hiroi, Sadayuki ^b   Seki, Shuhji ^b   Sakamoto, Toshihisa ^b  

^a CHUO UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c OCHANOMIZU UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Fatty liver; Kupffer cells; Lipid droplets; Lipid metabolism; Resveratrol

Indexed keywords

MUS;

CD68 PROTEIN, MOUSE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PERILIPIN 2; RESVERATROL; STILBENE DERIVATIVE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; FATTY LIVER; GENETICS; KUPFFER CELL; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE; ORGAN SIZE; PROTEOMICS;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DIET, HIGH-FAT; DOWN-REGULATION; FATTY LIVER; KUPFFER CELLS; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; ORGAN SIZE; PROTEOMICS; STILBENES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930181496     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400564     Document Type: Article

References (49)

1. Li, C., Yan, Z., Yang, J., Chen, H. et al., Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats. Neurochem. Int. 2010, 56, 495-500.
2. Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J. Neuroophthalmol. 2010, 30, 328-339.
3. Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M. et al., Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci, 2007, 80, 1033-1039.
4. Tunali-Akbay, T., Sehirli, O., Ercan, F., Sener, G., Resveratrol protects against methotrexate-induced hepatic injury in rats. J. Pharm. Pharm. Sci. 2010, 13, 303-310.
5. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, M. J. et al., One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am. J. Cardiol. 2012, 110, 356-363.
6. Toklu, H. Z., Sehirli, O., Ersahin, M., Suleymanoglu, S. et al., Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. J. Pharm. Pharmacol. 2010, 62, 1784-1793.
7. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A. et al., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444, 337-342.
8. Bujanda, L., Hijona, E., Larzabal, M., Beraza, M. et al., Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol. 2008, 8, 40.
9. Gomez-Zorita, S., Fernandez-Quintela, A., Macarulla, M. T., Aguirre, L. et al., Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Br. J. Nutr. 2012, 107, 202-210.
10. Shang, J., Chen, L. L., Xiao, F. X., Sun, H. et al., Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol. Sin. 2008, 29, 698-706.
11. Andrade, J. M., Paraiso, A. F., de Oliveira, M. V., Martins, A. M. et al., Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Nutrition 2014, 30, 915-919.
12. Poulsen, M. M., Larsen, J. O., Hamilton-Dutoit, S., Clasen, B. F. et al., Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. Nutr. Res. 2012, 32, 701-718.
13. Ahn, J., Cho, I., Kim, S., Kwon, D., Ha, T., Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J. Hepatol. 2008, 49, 1019-1028.
14. Nishikawa, K., Hashimoto, M., Itoh, Y., Hiroi, S. et al., Detection of changes in the structure and distribution map of triacylglycerol in fatty liver model by MALDI-SpiralTOF. FEBS Open Bio. 2014, 4, 179-184.
15. Krauss, S., Zhang, C. Y., Lowell, B. B., The mitochondrial uncoupling-protein homologues. Nat. Rev. Mol. Cell Biol. 2005, 6, 248-261.
16. Park, S. J., Ahmad, F., Philp, A., Baar, K. et al., Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148, 421-433.
17. Shono, S., Habu, Y., Nakashima, M., Sato, A. et al., The immunologic outcome of enhanced function of mouse liver lymphocytes and Kupffer cells by high-fat and high-cholesterol diet. Shock 2011, 36, 484-493.
18. Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S. et al., M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 2014, 59, 130-142.
19. Seki, S., Habu, Y., Kawamura, T., Takeda, K. et al., The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol. Rev. 2000, 174, 35-46.
20. Shiozaki, M., Hayakawa, N., Shibata, M., Koike, M. et al., Closer association of mitochondria with lipid droplets in hepatocytes and activation of Kupffer cells in resveratrol-treated senescence-accelerated mice. Histochem. Cell Biol. 2011, 136, 475-489.
21. Lefkowitch, J. H., Haythe, J. H., Regent, N., Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod. Pathol. 2002, 15, 699-704.
22. Kinoshita, M., Uchida, T., Sato, A., Nakashima, M. et al., Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J. Hepatol. 2010, 53, 903-910.
23. Ikarashi, M., Nakashima, H., Kinoshita, M., Sato, A. et al., Distinct development and functions of resident and recruited liver Kupffer cells/macrophages. J. Leukoc. Biol. 2013, 94, 1325-1336.
24. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
25. Kawabata, T., Kinoshita, M., Inatsu, A., Habu, Y. et al., Functional alterations of liver innate immunity of mice with aging in response to CpG-oligodeoxynucleotide. Hepatology 2008, 48, 1586-1597.
26. Hiroi, S., Nakanishi, K., Kawai, T., Expressions of human telomerase mRNA component (hTERC) and telomerase reverse transcriptase (hTERT) mRNA in effusion cytology. Diagn. Cytopathol. 2003, 29, 212-216.
27. Robenek, H., Hofnagel, O., Buers, I., Robenek, M. J. et al., Adipophilin-enriched domains in the ER membrane are sites of lipid droplet biogenesis. J. Cell Sci. 2006, 119, 4215-4224.
28. Brasaemle, D. L., Barber, T., Wolins, N. E., Serrero, G. et al., Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid Res. 1997, 38, 2249-2263.
29. Larigauderie, G., Furman, C., Jaye, M., Lasselin, C. et al., Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 504-510.
30. Larigauderie, G., Cuaz-Perolin, C., Younes, A. B., Furman, C. et al., Adipophilin increases triglyceride storage in human macrophages by stimulation of biosynthesis and inhibition of beta-oxidation. FEBS J. 2006, 273, 3498-3510.
31. Jiang, H. P., Serrero, G., Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. Proc. Natl. Acad. Sci. USA 1992, 89, 7856-7860.
32. Robenek, H., Robenek, M. J., Buers, I., Lorkowski, S. et al., Lipid droplets gain PAT family proteins by interaction with specialized plasma membrane domains. J. Biol. Chem. 2005, 280, 26330-26338.
33. Robenek, H., Robenek, M. J., Troyer, D., PAT family proteins pervade lipid droplet cores. J. Lipid Res. 2005, 46, 1331-1338.
34. Buechler, C., Ritter, M., Duong, C. Q., Orso, E. et al., Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochim. Biophys. Acta 2001, 1532, 97-104.
35. Mak, K. M., Ren, C., Ponomarenko, A., Cao, Q., Lieber, C. S., Adipose differentiation-related protein is a reliable lipid droplet marker in alcoholic fatty liver of rats. Alcohol Clin. Exp. Res. 2008, 32, 683-689.
36. Heid, H. W., Moll, R., Schwetlick, I., Rackwitz, H. R., Keenan, T. W., Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 1998, 294, 309-321.
37. Chang, B. H., Li, L., Paul, A., Taniguchi, S. et al., Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol. Cell Biol. 2006, 26, 1063-1076.
38. Chen, F. L., Yang, Z. H., Wang, X. C., Liu, Y. et al., Adipophilin affects the expression of TNF-alpha, MCP-1, and IL-6 in THP-1 macrophages. Mol. Cell Biochem. 2010, 337, 193-199.
39. Wang, X., Reape, T. J., Li, X., Rayner, K. et al., Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions. FEBS Lett. 1999. 462, 145-150.
40. Liu, Q., Dai, Z., Liu, Z., Liu, X. et al., Oxidized low-density lipoprotein activates adipophilin through ERK1/2 signal pathway in RAW264.7 cells. Acta Biochim. Biophys. Sin. 2010, 42, 635-645.
41. Vosper, H., Patel, L., Graham, T. L., Khoudoli, G. A. et al., The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J. Biol. Chem. 2001, 276, 44258-44265.
42. Larigauderie, G., Bouhlel, M. A., Furman, C., Jaye, M. et al., Perilipin, a potential substitute for adipophilin in triglyceride storage in human macrophages. Atherosclerosis 2006, 189, 142-148.
43. Davies, L. C., Jenkins, S. J., Allen, J. E., Taylor, P. R., Tissue-resident macrophages. Nat. Immunol. 2013, 14, 986-995.
44. DeTaeye, B. M., Novitskaya, T., McGuinness, O. P., Gleaves, L. et al., Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 2007. 293, E713-E725.
45. Polyzos, S. A., Kountouras, J., Papatheodorou, A., Patsiaoura, K. et al., Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2013, 62, 121-126.
46. Nakashima, H., Ogawa, Y., Shono, S., Kinoshita, M. et al., Activation of CD11b+ Kupffer cells/macrophages as a common cause for exacerbation of TNF/Fas-ligand-dependent hepatitis in hypercholesterolemic mice. PLoS One 2013, 8, e49339.
47. Ristig, M., Drechsler, H., Powderly, W. G., Hepatic steatosis and HIV infection. AIDS Patient Care STDS 2005, 19, 356-365.
48. Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H. et al., Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011. 14, 612-622.
49. Faghihzadeh, F., Adibi, P., Rafiei, R., Hekmatdoost, A., Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr. Res. 2014. 34, 837-843.